Financial Data : Zeria Pharmaceutical Co.,Ltd.


	Top		>		Financial Data

For the fiscal year ended March 31, 2012

Financial Summary (PDF/72KB)

For the fiscal year ended March 31, 2011

Financial Summary (PDF/50KB)

For the fiscal year ended March 31, 2010

Financial Summary (PDF/49KB)

For the fiscal year ended March 31, 2009

Financial Summary (PDF/50KB)

For the fiscal year ended March 31, 2008

Financial Summary (PDF/109KB)

For the fiscal year ended March 31, 2007

Financial Summary (PDF/96KB)

For the interim period of fiscal year ending March 31, 2007

		Consolidated Financial Summary (PDF/163KB)

		Non-consolidated Financial Summary (PDF/139KB)

For the fiscal year ended March 31,2006

		Consolidated Financial Summary (PDF/141KB)

		Non-consolidated Financial Summary (PDF/151KB)

For the interim period of fiscal year ending March 31,2006

		Consolidated Financial Summary (PDF/72KB)

		Non-consolidated Financial Summary (PDF/71KB)

For the fiscal year ended March 31,2005

		Consolidated Financial Summary (PDF/67KB)

		Non-consolidated Financial Summary (PDF/64KB)

For the fiscal year ended March 31,2012

58th Business Report (From April 1,2011 to March 31,2012.) (PDF/1,265KB)

For the fiscal year ended March 31,2011

57th Business Report (From April 1,2010 to March 31,2011.) (PDF/1,236KB)

For the fiscal year ended March 31,2010

56th Business Report (From April 1,2009 to March 31,2010.) (PDF/1,278KB)

[ ]···Consolidated

Fiscal year ended	March 2007	March 2008	March 2009	March 2010	March 2011	March 2012
Sales (million yen)	52,025 [ 52,757 ]	48,931 [ 49,721 ]	46,670 [ 47,670 ]	47,861 [ 50,745 ]	42,235 [ 49,482 ]	44,972 [ 53,169 ]
Ordinary income (million yen)	3,311 [ 3,341 ]	2,194 [ 2,446 ]	1,249 [ 1,366 ]	1,310 [ 1,467 ]	2,363 [ 3,158 ]	2,852 [ 4,417 ]
Net income (million yen)	2,149 [ 2,068 ]	1,534 [ 1,639 ]	1,160 [ 1,203 ]	878 [ 1,001 ]	1,385 [ 1,842 ]	1,892 [ 2,861 ]
Capital stock (million yen)	6,593	6,593	6,593	6,593	6,593	6,593
No. of shares issued (1,000 shares)	48,290	48,290	48,290	48,290	48,290	48,290
Net income per share (yen)	50.88 [ 48.96 ]	36.64 [ 39.15 ]	27.87 [ 28.91 ]	21.23 [ 24.21 ]	33.49 [ 44.55 ]	45.78 [ 69.19 ]
ROE (Return on equity)(%)	7.4 [ 7.0 ]	5.3 [ 5.6 ]	4.2 [ 4.2 ]	3.2 [ 3.6 ]	5.1 [ 6.5 ]	6.6 [ 9.8 ]
Dividend payout ratio (%)	31.4	43.7	57.4	75.4	56.7	50.2
No. of employees	1,134 [ 1,171 ]	1,095 [ 1,131 ]	1,065 [ 1,159 ]	1,073 [ 1,280 ]	1,046 [ 1,287 ]	1,054 [ 1,297 ]
Shareholders' equity (million yen)	29,214 [ 29,597 ]	28,474 [ 28,962 ]	27,182 [ 27,711 ]	27,292 [ 27,995 ]	27,265 [28,423 ]	28,786 [ 30,494 ]
Total assets (million yen)	56,539 [ 58,519 ]	54,205 [ 56,424 ]	55,581 [ 58,110 ]	66,735 [ 70,971 ]	68,031 [ 73,779 ]	69,110 [ 75,201 ]
Plant and equipment investment (million yen) Tangible and intangible long-term prepaid expenses	3,646 [ 3,651 ]	1,299 [ 1,427 ]	1,346 [ 1,379 ]	857 [ 1,844 ]	790 [ 1,911 ]	1,276 [ 1,752 ]
Depreciation (million yen) Tangible and intangible long-term prepaid expenses	1,587 [ 1,609 ]	2,058 [ 2,080 ]	2,192 [ 2,234 ]	2,202 [ 2,313 ]	2,189 [ 2,316 ]	2,273 [ 2,491 ]
R&D (million yen)	5,767 [ 5,772 ]	5,381 [ 5,387 ]	5,122 [ 5,128 ]	5,589 [ 5,865 ]	4,299 [ 5,281 ]	4,334 [ 5,308 ]
Ratio of shareholders' equity to total assets (%)	51.7 [ 50.6 ]	52.5 [ 51.3 ]	48.9 [ 47.7 ]	40.9 [ 39.4 ]	40.1 [ 38.4 ]	41.7 [ 40.4 ]
Shareholders' equity per share (yen)	694.46 [ 703.57 ]	683.35 [ 695.05 ]	656.92 [ 669.72 ]	659.77 [ 676.77 ]	659.32 [ 684.87 ]	696.24 [ 734.06 ]
Dividends per share (yen) (of which, interim dividends per share)	16.00 (8.00)	16.00 (8.00)	16.00 (8.00)	16.00 (8.00)	19.00 (9.00)	23.00 (11.00)
Retio of net income to sales (%)	4.1 [ 3.9 ]	3.1 [ 3.2 ]	2.4 [ 2.5 ]	1.8 [ 2.0 ]	3.3 [ 3.7 ]	4.2 [ 5.4 ]

Fiscal year ended	March 2007	March 2008	March 2009	March 2010	March 2011	March 2012
Cash flow from business activities (million yen)	2,749	3,759	423	5,858	5,847	6,028
Cash flow from investment activities (million yen)	△4,876	△2,096	△3,363	△15,479	△7,292	△2,566
Cash flow from financial activities (million yen)	2,136	△1,335	△3,258	10,373	2,838	△2,433